364 related articles for article (PubMed ID: 29673870)
21. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration.
Gómez EC; Anguiano Igea S; Gómez Amoza JL; Otero Espinar FJ
Eur J Pharm Sci; 2018 May; 117():270-278. PubMed ID: 29501459
[TBL] [Abstract][Full Text] [Related]
23. A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.
Rizi K; Xu K; Begum T; Faull J; Bhakta S; Murdan S
Int J Pharm; 2022 Feb; 614():121437. PubMed ID: 34973408
[TBL] [Abstract][Full Text] [Related]
24. Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
Cutrín-Gómez E; Anguiano-Igea S; Delgado-Charro MB; Gómez-Amoza JL; Otero-Espinar FJ
Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30551601
[TBL] [Abstract][Full Text] [Related]
25. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
26. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
27. Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.
Chularojanamontri L; Pattanaprichakul P; Leeyaphan C; Suphatsathienkul P; Wongdama S; Bunyaratavej S
Biomed Res Int; 2021; 2021():9113418. PubMed ID: 34938812
[TBL] [Abstract][Full Text] [Related]
28.
Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
[TBL] [Abstract][Full Text] [Related]
29. [Distribution of Luliconazole in Nail Plate by In Vitro Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution].
Shimamura T; Miyamae A; Arai M; Minemura A; Nozawa A; Kubota N
Med Mycol J; 2016; 57(1):J19-25. PubMed ID: 26936348
[TBL] [Abstract][Full Text] [Related]
30. Emerging topical onychomycosis therapies - quo vadis?
Elkeeb R; Hui X; Murthy N; Maibach HI
Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
[TBL] [Abstract][Full Text] [Related]
31. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Luc J; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):89-94. PubMed ID: 1831626
[TBL] [Abstract][Full Text] [Related]
32. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
33. Do fungi play a role in psoriatic nails?
Szepietowski JC; Salomon J
Mycoses; 2007 Nov; 50(6):437-42. PubMed ID: 17944702
[TBL] [Abstract][Full Text] [Related]
34. Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: implications for drug delivery.
Nogueiras-Nieto L; Gómez-Amoza JL; Delgado-Charro MB; Otero-Espinar FJ
J Control Release; 2011 Dec; 156(3):337-44. PubMed ID: 21906642
[TBL] [Abstract][Full Text] [Related]
35. A pharmaceutics perspective on drug delivery to the nail: recent advances and challenges.
Delgado-Charro MB
Ther Deliv; 2015 Jul; 6(7):773-5. PubMed ID: 26228770
[No Abstract] [Full Text] [Related]
36. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
Palliyil B; Lebo DB; Patel PR
AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
[TBL] [Abstract][Full Text] [Related]
37. Fractional CO
Ortner VK; Nguyen N; Brewer JR; Solovyeva V; Haedersdal M; Philipsen PA
Lasers Surg Med; 2022 Aug; 54(6):861-874. PubMed ID: 35451510
[TBL] [Abstract][Full Text] [Related]
38. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
[TBL] [Abstract][Full Text] [Related]
39. Iontophoretic drug delivery across the nail.
Delgado-Charro MB
Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
[TBL] [Abstract][Full Text] [Related]
40. 1st meeting on topical drug delivery to the nail.
Murdan S
Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
